Altimmune, Inc. (ALT) Is At $1.61 Formed Wedge; 2 Analysts Are Bullish Sharps Compliance Corp. (SMED) Last Week

Among 2 analysts covering Sharps Compliance (NASDAQ:SMED), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Sharps Compliance had 6 analyst reports since September 23, 2015 according to SRatingsIntel. Stifel Nicolaus maintained the shares of SMED in report on Thursday, October 26 with “Buy” rating. The firm has “Buy” rating by Stifel Nicolaus given on Wednesday, September 23. The stock of Sharps Compliance Corp. (NASDAQ:SMED) has “Buy” rating given on Wednesday, July 19 by Stifel Nicolaus. The rating was downgraded by First Analysis to “Equal-Weight” on Friday, August 12. The rating was maintained by Stifel Nicolaus on Friday, August 11 with “Buy”. The company was upgraded on Monday, August 14 by First Analysis. See Sharps Compliance Corp. (NASDAQ:SMED) latest ratings:

26/10/2017 Broker: Stifel Nicolaus Rating: Buy Old Target: $7 New Target: $6 Maintain

Altimmune, Inc. (ALT) formed wedge down with $1.48 target or 8.00% below today’s $1.61 share price. Altimmune, Inc. (ALT) has $25.16M valuation. The stock increased 1.90% or $0.03 during the last trading session, reaching $1.61. About 199,143 shares traded. Altimmune, Inc. (NASDAQ:ALT) has 0.00% since March 5, 2017 and is . It has underperformed by 16.70% the S&P500.

The stock decreased 2.78% or $0.13 during the last trading session, reaching $4.55. About 4,949 shares traded. Sharps Compliance Corp. (NASDAQ:SMED) has risen 1.67% since March 5, 2017 and is uptrending. It has underperformed by 15.03% the S&P500.

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. The company has market cap of $73.17 million. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web compliance and training program. It has a 568.75 P/E ratio. The firm also provides Route-Based Pickup Service, a waste management service, which offers medical and hazardous waste pick-up services; TakeAway Recycle System, a solution for the collection and recycling of single-use medical devices from surgical centers and other healthcare facilities; and Universal Waste Shipback Systems, a solution for the collection, transportation, and recycling of light bulbs, batteries, and other mercury containing devices.

Investors sentiment increased to 1.57 in Q3 2017. Its up 0.44, from 1.13 in 2017Q2. It improved, as 0 investors sold Sharps Compliance Corp. shares while 7 reduced holdings. 4 funds opened positions while 7 raised stakes. 4.06 million shares or 1.96% more from 3.99 million shares in 2017Q2 were reported. Geode Cap Management Ltd stated it has 57,439 shares. Blackrock reported 101,658 shares. Thompson Davis owns 1,750 shares for 0.01% of their portfolio. Heartland holds 493,429 shares or 0.15% of its portfolio. Tower Research Cap Ltd (Trc) invested in 0% or 2,227 shares. Northern Corp reported 26,647 shares. North Star Investment Mngmt Corp reported 193,350 shares. Comml Bank Of New York Mellon holds 0% in Sharps Compliance Corp. (NASDAQ:SMED) or 13,726 shares. 399,000 are held by Renaissance Technology Ltd Liability Corporation. Goodman stated it has 1.01 million shares or 2.35% of all its holdings. The Connecticut-based Lapides Asset Llc has invested 0.17% in Sharps Compliance Corp. (NASDAQ:SMED). Gsa Capital Ptnrs Llp stated it has 28,858 shares. Anderson Hoagland & Co has invested 0.07% in Sharps Compliance Corp. (NASDAQ:SMED). 398,600 are owned by Ranger Ltd Partnership. Morgan Stanley has 125,626 shares.